Newsletter

Clinical Trials: Sugar Pill

Clinical Trials: Sugar Pill
Transcript

Barbara: "I don't want to do the clinical trial. What if I'm the one who gets the sugar pill?" Cooper: "Yeah, I mean all that time and energy for nothing?" Dr. Theo: "Great question. Even when clinical trials are going to be using placebo, there are ways to design a trial to make sure that patients will get an active treatment - a real treatment - for the condition either right in the beginning or within a few weeks of starting the trial. Let me give you two examples: There are some trials where you will get study drug or placebo, but if the patient's not doing well after say 10 weeks, they're guaranteed of getting study drug automatically. Here is a second possibility very commonly used in cancer trials: All the patients will get established study treatment that's out there - so everybody's getting standard of care - some patients will (in addition) get a boost with study drug while others will get placebo. One other thing we can do to make sure that more patients actually get the boost rather than the placebo: For example, 2/3 of the patients may get the study drug and only 1/3 get the placebo."

Related Videos

Clinical Trials: Sugar Pill

What is a Clinical Trial?

Clinical Trials: Are They Expensive?

Clinical Trials: Are They Safe?

Clinical Trials: Benefits & Risks

Clinical Trials: Can I Back Out?

Clinical Trials: Will I Get Paid?

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Doctor Profile

Theo Brandt-Sarif, MD

Clinical Trials Expert

  • Consultant physician specializing in clinical trials
  • MBA from The Wharton School
  • Extensive experience accelerating patient accrual into trials that are lagging their enrollment goals

Clinical Trials

Effect of Whole Fruit on Glycemic Control in Adults With Type 2 Diabetes

The University of Alabama at Birmingham is studying how a healthy diet can p

SweetMama: Testing of Technology for Diabetes Education for Pregnant Women

SweetMama is a new technological tool created to provide education for expecting mothers with type 2 diabetes. Inve

Transition to Adult Care in Type 1 Diabetes

The roles of care professional and support networks can change as teenagers with type 1 diabetes transition into ad

Veteran Support and Resources for Diabetes

This study aims to see if veterans with diabetes can navigate the state’s many available resources better wit

Emory Latino Diabetes Education Program

Latinos have an alarmingly high rate of developing diabetes as the largest United States minority group. This is wh

Nutrition Education Intervention for Adults With Type 2 Diabetes

The goal of this study is to implement a nutrition education intervention for adults with type 2 diabetes mellitus adapted from a primary health ca

Estrogen and Diabetes

It has been proven women with type 1 diabetes have a 2 to 3 fold greater risk of cardiovascular disease (CVD) than men. This study attempts to dete

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes

At the University of Maryland, researchers are conducting a double blind study of the effects of SSRI medication fluoxetine (Prozac) on the Autonom

Women in Control: A Virtual World Study of Diabetes Self-Management

This study compares the effectiveness of a diabetes self management (DSM) group medical visit in the virtual world (Second life) to a face-to-face

Send this to a friend